Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Duffull

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
The Journal of Antimicrobial Chemotherapy|April 4, 2025
Evaluation of an optimized intermittent vancomycin dosing regimen in infantsAmanda L Wilkins, Wenyu Yang, Stephen B Duffull, et al.
The AAPS Journal|February 20, 2016
The Population Pharmacokinetics of D-β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-HydroxybutyrateVittal Shivva, Pete J Cox, Kieran Clarke, et al.
Malaria Journal|May 4, 2012
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malariaKris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
British Journal of Clinical Pharmacology|August 14, 2008
Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infectionJuliana F Roos, Carl M J Kirkpatrick, Susan E Tett, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 15, 2011
Modeling red blood cell survival dataJulia Korell, Frederiek E Vos, Carolyn V Coulter, et al.
British Journal of Clinical Pharmacology|July 18, 2006
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulationYan Feng, Bruce Green, Stephen B Duffull, et al.
Therapeutic Drug Monitoring|December 1, 2004
Sampling times for monitoring tacrolimus in stable adult liver transplant recipientsChantaratsamon Dansirikul, Christine E Staatz, Stephen B Duffull, et al.
Pharmaceutical Statistics|July 24, 2009
The time course of drug effectsHesham S Al-Sallami, Venkata V Pavan Kumar, Cornelia B Landersdorfer, et al.
The New Zealand Medical Journal|August 3, 2012
Dabigatran: rational dose individualisation and monitoring guidance is neededStephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, et al.
ACS Pharmacology & Translational Science|December 16, 2022
In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1<i>H</i>-indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?Hayley M Green, David B Finlay, Ruth A Ross, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Antimicrobial Chemotherapy|April 4, 2025
Evaluation of an optimized intermittent vancomycin dosing regimen in infantsAmanda L Wilkins, Wenyu Yang, Stephen B Duffull, et al.
The AAPS Journal|February 20, 2016
The Population Pharmacokinetics of D-β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-HydroxybutyrateVittal Shivva, Pete J Cox, Kieran Clarke, et al.
Malaria Journal|May 4, 2012
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malariaKris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
British Journal of Clinical Pharmacology|August 14, 2008
Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infectionJuliana F Roos, Carl M J Kirkpatrick, Susan E Tett, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 15, 2011
Modeling red blood cell survival dataJulia Korell, Frederiek E Vos, Carolyn V Coulter, et al.
British Journal of Clinical Pharmacology|July 18, 2006
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulationYan Feng, Bruce Green, Stephen B Duffull, et al.
Therapeutic Drug Monitoring|December 1, 2004
Sampling times for monitoring tacrolimus in stable adult liver transplant recipientsChantaratsamon Dansirikul, Christine E Staatz, Stephen B Duffull, et al.
Pharmaceutical Statistics|July 24, 2009
The time course of drug effectsHesham S Al-Sallami, Venkata V Pavan Kumar, Cornelia B Landersdorfer, et al.
The New Zealand Medical Journal|August 3, 2012
Dabigatran: rational dose individualisation and monitoring guidance is neededStephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, et al.
ACS Pharmacology & Translational Science|December 16, 2022
In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1<i>H</i>-indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?Hayley M Green, David B Finlay, Ruth A Ross, et al.
Pageof 18